There are many drugs on the market to help slow the progress of diseases such as leukemia and other types of cancer. One popular medication is Tasigna. Also known as Nilotinib, Tasigna is an oral medication prescribed for Chronic Myeloid Leukemia (CML.) It is typically given after a person has exhausted other treatment methods
Chronic Myeloid Leukemia occurs when bone marrow makes too many white blood cells. It is a curable type of cancer, but it can become chronic if not treated promptly and effectively.
Tasigna, manufactured by Novartis, works by inhibiting tyrosine kinases, which causes cancer cells to activate and grow. The drug causes these cancer cells to stop producing and causing damage to heathy cells.
Tasigna Athetrosclerosis Side Effect
Like most drugs, Tasigna has some side effects. Common side effects include: headaches, nausea, fatigue, joint or muscle pain, itching, skin rashes, diarrhea, constipation and hair loss. Some side effects are more severe, including swelling in the hands and feet, rapid weight gain, painful urination, severe stomach pain, high blood sugar and liver disease.
Atherosclerosis is a serious side effect associated with Tasigna use. This disease develops when plaque develops inside the arteries. Atherosclerosis can affect arteries in the kidneys, brain, heart, arms, and legs. It can lead to other serious medical conditions such as chronic kidney disease, coronary heart disease, carotid artery disease and peripheral artery disease. Novartis is now facing lawsuits from patients who suffered adverse reactions from the drug.
If you or a loved one use Tasigna and developed atherosclerosis, call the Tasigna Lawsuit Claim Center now at 1-800-718-4658. We will answer all of your questions and provide you with a 100% free and confidential case evaluation. Don’t wait as there are strict time limits for making a claim, contact us now. We are pursuing these claims throughout the country.
Tasigna Wrongful Death Lawsuit
Novartis has received reports of Tasigna causing severe, accelerated and irreversible atherosclerosis in users. The drug has been linked to one death in California. The family of the deceased man filed a wrongful death lawsuit in March 2016. The lawsuit alleges that Novartis was aware of the reports of atherosclerosis found in those who took Tasigna. The man allegedly died from an atherosclerosis-related condition and the suit alleges that Novartis failed to sufficiently warn doctors and patients of the dangerous side effects. After the lawsuit was filed, it was discovered that Novartis warned patients in Canada, but not in the United States.
Did Novartis Hide Dangers of Tasigna?
Drug manufacturers have a duty to put safe medications on the market. While every drug carries side effects to some degree, drugs that can cause death are deemed too dangerous to be put on the market. Manufacturers are held to high standards and if they discover situations in which a drug can cause serious harm or death, they must do the right thing and issue a recall. This takes the drug off the market to avoid harming other patients.
When manufacturers know their drugs are harmful, but continue to market them anyway, this is dishonest and unethical. Manufacturers can be held liable for injuries and deaths caused by a dangerous drug. Those affected by the drug can file lawsuits against the manufacturers and obtain compensation for damages.
So, why would a company knowingly hide dangerous side effects from consumers and physicians? One word: money. When a company takes a popular, money-making drug off the market, it affects a company’s revenue dramatically. In the case of Novartis, it would lose out on a significant amount of revenue. In 2017, sales of Tasigna topped $1.8 billion and sales were expected to continue to grow.
By 2020, the cancer drug market is expected to reach $111 billion. Drug companies are heavily competing with each other and therefore hesitant to give up any market share to other companies – even if adverse side effects are at play.
Think you may have a claim? If so, don’t wait. Contact us now at 1-800-718-4658 for a free case evaluation. We will answer your questions, review your case and let you know if you have a claim. You can use the live chat feature, contact form or call our Tasigna legal team at 1-800-718-4658. We are pursuing claims nationwide.
Tasigna FDA Warning
While Tasigna has not yet been recalled, the Food and Drug Administration (FDA) has updated the drug’s product label to add guidelines as to when a patient can discontinue use of the drug. Tasigna is not meant to be used permanently, as patients tend to reach levels of remission after 1-2 years of use.
While the FDA has updated guidelines for Tasigna use, the drug has yet to be recalled. Despite the growing number of studies linking Tasigna to atherosclerosis and other side effects, Novartis is not likely to recall the drug anytime soon.
Have You Used Tasigna And Developed Atherosclerosis?
If you have developed atherosclerosis or some other serious side affect after taking Tasigna, you may be able to file a lawsuit. Novartis allegedly was aware of the risks involved with Tasigna use, but failed to disclose them to doctors and patients in the United States.
The Tasigna Lawsuit Attorneys at Nadrich & Cohen are actively investigating Tasigna atherosclerosis side effect claims. If you or a loved one has been diagnosed with atherosclerosis after using Tasigna, you may be able to make a claim.
Don’t wait, call us now for a free and confidential consultation. If you have a claim, you may be entitled to compensation for medical expenses, injury, future medical treatment and testing, pain and suffering and more.
Call 1-800-718-4658 now for your free case evaluation. We handle Tasigna side effect cases coast-to-coast.